ABSTRACT: Neurotrophins are essential proteins for the development and maintenance of neural functions as well as promising drugs in neurodegenerative disorders. Current limits in their effective clinical applications can be overwhelmed by the combined use of peptidomimetic and nanomedicine approaches. Indeed, neurotrophin-mimicking peptides may allow minimizing the adverse side effects of the whole protein drug. Moreover, the immobilization of such peptides on nanomaterials may offer additional advantages, including protection against degradation, enhanced permeability of barrier membranes, and intrinsic therapeutic properties of the nanoparticles (e.g., antiangiogenic and plasmonic features of gold nanoparticles (AuNPs)). In the present article, we scrutinize the functionalization of spherical AuNPs of diameter 12 nm by peptides because of the N-terminal domains of the nerve growth factor (NGF) and the brain-derived neurotrophic factor (BDNF), NGF1-14 and BDNF1-12, respectively. The hybrid gold−peptide nanobiointerface was investigated, both in the direct physisorption and in the lipid-bilayer-mediated adsorption processes, by a multitechnique study that included UV−vis and X-ray photoelectron spectroscopies, dynamic light scattering, zeta-potential analyses, and atomic force microscopy. Both peptide-and lipid-dependent features were identified, to have a modulation in the peptide coverage of nanoparticles as well as in the cellular uptake of NGF and BDNF peptides, as investigated by confocal microscopy. The promising potentials of the neurotrophins to cross the blood−brain barrier were demonstrated.
INTRODUCTION
Nanoparticle-based platforms have recently attracted much attention for the delivery of drugs and molecules with neuroprotective and regenerative activities that, under normal conditions, cannot pass through the blood−brain barrier (BBB), the vital interface between the neural tissue and circulating blood. 1, 2 Neurotrophin proteins, produced by the cells of the central nervous system (CNS), are growth factors regulating the neuron division, survival, and neurite outgrowth. 3, 4 A forefront medicine research area deals with making neurotrophins a clinical reality for people suffering from disorders, involving neuronal degeneration (such as Alzheimer's, Huntington's, and Parkinson's disease) 5−7 and physical trauma resulting in the severing of nerve connections (i.e., accidents and sports-related injuries). 8 Despite the great potential of neurotrophic factors in the therapeutic action, their clinical application has been so far limited because of their poor plasma stability, low penetration of the BBB, and serious side effects, such as pain. 9, 10 So far, only few cases of neurotrophin-based drugs have been approved for use in humans, that is, for administering opioids in chronic pain management and as antisplasticity drugs for spinal cord injury. 8 The potential of neurotrophin-based drugs can be enhanced by new hybrid systems comprising (1) peptides capable of mimicking the whole proteins by retaining their functionality of neurotrophic action 11 and (2) nanoparticles capable of binding the neurotrophin-like drug by either physical or chemical immobilization, 12, 13 where the drug-delivery capability and the ability to cross the BBB could be finely controlled over their size, surface charge, hydrophobicity, shape, coating, and chemistry. 1,14−17 We have recently demonstrated that peptide sequences NGF1-14 and BDNF1-12, which encompass the N-terminal domain of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), respectively, exhibit neurotrophin-mimicking capabilities also upon immobilization on the solid gold surface. 18, 19 In the present study, we move a step forward on the fabrication and biological validation of the hybrid nanobiointerface established between neurotrophin peptides and gold nanoparticles (AuNPs) that represents an attractive scaffold to construct a multifaceted theranostic platform (Scheme 1).
Indeed, AuNPs provide an excellent nanocarrier for the modulation of interfacial processes in biological and material applications. 20 For example, AuNPs possess intrinsic antiangiogenic 21 and anti-inflammatory activities; 22 also, because of their plasmonic properties, they are suitable for light-triggered response (e.g., hyperthermia in tumor treatment 23 ) and optical imaging (biosensing 24, 25 ). Furthermore, drug-functionalized AuNPs might be able to cross the BBB and allow for a target-specific delivery of the active molecules to the neurons of the CNS. 15 In general, AuNPs can open highly structured tight junctions that connect endothelial cells, which are the main components of the brain microvascular anatomy, together with the basement membrane and neighboring cells, 26 including pericytes, astrocytes, neurons, and microglia (neurovascular unit). 27 Overall, they contribute to create selective permeability for the entry of molecules between the systemic circulation and nervous tissue, maintaining the CNS homeostasis.
To enhance the image-contrast capability of the newly assembled platform, 28 the NGF-and BDNF-like peptides were dye-labeled with carboxyfluorescein (Fam) through an additional lysine (K) residue at the C-terminus, to obtain SSSHPIFHRGEFSV-K-Fam (NGF p F) and HSDPARR-GELSV-K-Fam (BDNF p F), respectively.
RESULTS AND DISCUSSION
To modulate the peptide−metal surface interaction, a dual approach, involving direct adsorption and a lipid-mediated interaction between the peptide and the gold surfaces, was used.
In the latter case, either NGF p P or BDNF p F was loaded in small unilamellar vesicles (SUVs) of zwitterionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphorylcholine (POPC), to obtain NGF p F-PC or BDNF p F-PC, respectively.
The UV−vis titration spectra in Figure 1 show that a redshift of the plasmonic band associated with a small but significant (about 10% absorbance shift) hyperchromic effect is achieved by adding peptides at increasing concentrations. It must be noted that at higher peptide concentrations (≥10 −6 M), as shown in Figure 1 , the apparent downshift of λ is instead due to the absorption of the Fam moiety (λ max ∼490 nm) from NGF p F and BDNF p F peptides.
The saturation in the shifts of wavelength (Δλ) and absorbance (ΔA) is reached at the added peptide concentrations of 0.5 μM for NGF p F and 1 μM for BDNF p F, NGF p F-PC, and BDNF p F-PC. This finding suggest that at these concentrations the maximum size of the hybrid assembly comprising a metal core (AuNP) surrounded by a soft shell (peptide molecules) is obtained, as monitored in terms of the optical sensing of the hybrid interface by the plasmonic nanoparticle.
Indeed, the intensity of maximum absorbance increases and the wavelength of the localized surface plasmon resonance band peak shifts to longer wavelengths with increasing number of molecules adsorbed on the AuNP, due to the corresponding increase in the dielectric constant of the local regions near the interfaces of gold. 29, 30 The parallel occurrence of these two spectral features, as shown in Figure 1 , indicates that the size increase of the colloidal metal is mostly due to the "decoration" of the nanoparticle surface by the adsorbed peptide molecules rather than a partial aggregation phenomenon. 31 Specifically, as to the direct peptide−AuNP interaction (Figure 1a,b) , the plots of ΔA versus Δλ exhibit a direct onestep change for NGF p F but a two-step change for BDNF p F (see insets). Therefore, for NGF p F−AuNP and BDNF p F−AuNP interactions, the measured curve shifts likely depend on the different stages of the peptide adsorption process, which is in turn related to the possible diverse orientation/conformation of the molecules at the interface with the AuNP surface. Such a finding is in agreement with the dissimilar affinities of the two peptides toward the Au surface, as demonstrated for NGF and BDNF peptides at the interface with flat gold, resulting in viscoelastic and rigid adlayers, respectively. 18, 19 As to the lipid-mediated peptide−AuNP interaction ( Figure  1c,d) , a significant synergic effect from each component, that is, peptide, lipid, and AuNP, is monitored at the hybrid nanobiointerface. First, for NGF p F-PC, the peptide concentration at equilibrium, that is, the value corresponding to the saturation in the plasmonic peak shifts, increases up to 1 μM, comparable to that of BDNF p F-PC, with a corresponding calculated coverage of about 2.4 × 10 7 for both NGF p F-PC− AuNP and BDNF p F-PC−AuNP interfaces. This fact suggests an active role of the fluid lipid membrane in the confinement of NGF peptide at the interface with the gold surface. 32 Such an effect would prompt a more "ordered" interaction with AuNPs and therefore a higher number of molecules detected by the plasmonic sensing.
Second, the insets in Figure 1c ,d show also a peptide-driven effect, as both Δλ and ΔA are narrower for NGF p F-PC than for BDNF p F-PC, consistent with that observed for NGF p F and BDNF p F, respectively.
Third, the UV−vis spectra of pellets and supernatants recovered after the centrifugation step used to remove unbound In general, the centrifugation step, under the experimental conditions used, is efficient to collect, from the pellets, peptidefunctionalized AuNPs ( Figure S3 ). In particular, the comparison between the spectra of pellets and supernatants shows an almost totally irreversible adsorption for NGF p F and BDNF p F in the direct interaction with the AuNPs. On the other hand, for the lipid-mediated interaction, as the spectra of supernatants clearly display spectral features of free peptides and/or peptide/ PC systems, a partially reversible adsorption occurred. These findings indicate the possibility, through the lipid-mediated interaction, of modulating also the actual peptide coating onto AuNPs.
A semiquantitative estimation of the different interactions occurring between the two peptides and AuNPs can be obtained by the approximate nanoparticle coverage, calculated according to the peptide concentrations used to reach saturation in the UV−vis titration spectra. By considering spherical AuNPs with an average diameter (d) of 12 nm, the number of gold atoms can be calculated according to the formula: N = d 3 (πρ/6M), where ρ is the density of fcc Au (19.3 g/cm 3 ) and M is the atomic weight (197 g/mol). 33 The corresponding coverages, in terms of peptide molecules for each AuNP, are about 1.2 × 10 7 and 2.4 × 10 7 for NGF p F and BDNF p F, respectively.
Because the molecular dimensions of NGF p F and BDNF p F are 2.7 × 1.7 × 2.0 nm 3 and 3.2 × 1.7 × 1.6 nm 3 , respectively, the ideal nanoparticle coverage by the peptides (in terms of peptide molecules/AuNP) ranges from ∼85 to ∼130 for NGF p F and from ∼88 to ∼170 for BDNF p F in the two limit side-on and end-on configurations, respectively. Accordingly, "disordered" multilayers of NGF p F molecules in side-on/endon configuration (Scheme 1a) and more packed adlayers of BDNF p F molecules most likely in side-on configuration can be figured out at the interface with AuNP (Scheme 1b). Although the stirring may also cause the coalescence of AuNPs and a population of aggregated nanoparticles cannot be excluded, the characterization of the pellets resuspended in the MOPS buffer evidences, however, significant peptide-dependent differences, as demonstrated by zeta-potential (ZP), dynamic light scattering (DLS), and atomic force microscopy (AFM) analyses.
In particular, Table 1 shows that all of the peptideimmobilized AuNPs display a comparable surface charge neutralization but actual changes in the hydrodynamic diameters. 34, 35 Indeed, negatively charged bare AuNPs exhibit a surface charge decrease of about 30−40% in the MOPS buffer with respect to the same particles dispersed in water, likely due to the partial charge neutralization of citrate anions surrounding the metal core 22 by the Na + and K + ions used to fix the ionic strength of the buffer. A major charge decrease (∼80%) of AuNPs is found after the interaction with the bare lipid vesicles, whereas the measured charge is null for all of the peptide/ AuNP and peptide-PC/AuNP nanoparticles. This finding can be explained on the basis of the cationic character of both peptides (isoelectric pH of approximately 8−9 18 ) under the experimental conditions used.
Interestingly, the hydrodynamic diameter of bare AuNPs (D = 26 ± 2 nm, in both water and the MOPS buffer) increases differently for NGF p F/AuNP (250 ± 30 nm) and BDNF p F/ AuNP (75 ± 3 nm). According to the UV−vis data and the calculated nanoparticle coverage discussed above, these findings confirm the picture of peptide molecule multilayers organized, respectively, as extended (for NGF p F) and compact (for BDNF p F) adlayers at the interface with AuNPs.
Such a trend is also observed for lipid-loaded SUVs, where NGF p F-PC exhibits a higher average diameter (D = 122 ± 2 nm) than BDNF p F-PC (D = 104 ± 3 nm), which instead are comparable in size to control SUVs without peptide (D = 108 ± 5 nm). Therefore, NGF p F molecules tend to an extended end-on-like arrangement, whereas BDNF p F molecules more likely lie flat on the leaflet plane of the lipid membrane.
As to the hybrid peptide−lipid/AuNP samples, hydrodynamic diameters of 172 ± 28 nm for NGF p F-PC/AuNP (similar to 173 ± 34 nm measured for POPC SUV/AuNP) and 83 ± 7 nm for BDNF p F-PC/AuNP are found. A possible explanation is that for the lipid-mediated interaction of NGF p F with AuNP the lipids maintain their liposomal self-assembling state, whereas in the case of BDNF p F, the interaction with the metal nanoparticle can prompt the formation of different lipid supramolecular assemblies (e.g., supported lipid bilayers, having a thickness of about 5 nm 36 ). The characterization of the peptide/AuNP samples in air by AFM analyses (Figure 2) , although affected by additional aggregation effects because the samples were deposited on mica and dried, confirms, however, the actual nanoparticle coating by the peptides. In fact, from the height analysis of the particles, the average size of bare AuNPs (∼12 nm) increases up to ∼16 and ∼20 nm for NGF p F/AuNP and BDNF p F/AuNP, respectively. As to the peptide−lipid/AuNP samples, no relevant features could be detected on the solid-deposited samples, as the samples suffered the substrate effect on lipid assembly 36 ( Figure S4 ). The physicochemical characterization of the NGF p F/AuNP and BDNF p F/AuNP samples provided by X-ray photoelectron spectroscopy (XPS) further confirms the results obtained for the hybrid interfaces formed for the two peptides ( Figure 3) , with significant differences found for the peptide-immobilized samples with respect to bare AuNPs ( Figure S5 and Table S1 ).
For the peak-fitting analysis of C 1s, the following four components are considered: C 1 (at a binding energy (BE) of 285.0 eV), due to C−C and C−H hydrocarbon bonds; C 2 (at a BE of 286.2 ± 0.2 eV), assigned to heterocarbon C−O and C− N bonds; and C 3 and C 4 (at BEs of 288.2 ± 0.2 and 289.0 ± 0.2 eV, due to CO and C(O)OH groups, respectively). 37 Intrinsic structural differences due to the primary peptide sequence are clearly displayed in the carbon peak components found for NGF p F (Figure 3b ) and BDNF p F (Figure 3d ). In fact, the ratio of polar to apolar components ((C 2 + C 3 + C 4 )/ C 1 ) exhibited by the former and the latter are 1.3 and 3.2, respectively, according to the two extra amino acids in the NGF p F sequence and also two more phenylalanine residues in comparison with BDNF p F, which instead encompasses both one carboxylic residue and one guanidine extra residue. Interestingly, the comparison of C 1s spectra for NGF p F/ AuNP (Figure 3a) and BDNF p F/AuNP (Figure 3c ) samples suggest that the BDNF peptide molecules bind to the gold surface predominantly through the guanidine, carbonyl, and carboxyl groups (i.e., strong decrease of C 2 , C 3 , and C 4 components, respectively), according to the picture of molecules lying at the interface in the extended side-on arrangement. In the case of the NGF peptide, a minor change in the peak shape can be an indicator of a more localized interaction among certain sites of the peptide sequence and the AuNP, which results in a less ordered hybrid interface.
To test the transport of neurotrophin-peptide-functionalized AuNPs across the BBB, a cellular model of immortalized human brain microvascular endothelial cells (iHBMECs) was used. The HBMEC model is representative of human brain endothelium and exhibits barrier properties comparable to other BBB models. 38 First, cell viability was assessed to verify that the various peptide/lipid/AuNP assemblies were nontoxic under the experimental conditions used. No toxicity was found up to 24 h of cell treatment (Figure 4) . Second, as it is well known that AuNPs are capable of crossing the BBB, 15 the effect of the nanoparticle functionalization was here scrutinized in terms of cell internalization by the various peptide/lipid/AuNP assemblies, to find differences (if any) depending on the peptides and/or the immobilization approaches, for example, direct or lipid-mediated adsorption, used for tailoring the AuNPs. Figure 5 shows the representative images of laser scanning confocal microscopy (LSM) for cells incubated for 2 h with NGF p F and BDNF p F (emitting in the green, due to Fam moieties): free (Figure 5a ), immobilized on AuNPs by direct adsorption (Figure 5b ), loaded in rhodamine-labeled POPC SUVs (emitting in the red; Figure 5c ), and immobilized on AuNPs by lipid-mediated adsorption (Figure 5d ).
An enhancement of peptide internalization by the cells in the functionalized AuNPs compared with both free peptides and peptide-loaded SUVs is visible. Interestingly, for NGF p F/ AuNP, a higher peptide uptake (displayed by a diffuse green emission in the cytoplasm) and intracellular aggregation of the AuNPs (dark spots in the optical micrograph; open arrows in Figure 5b ) is found compared to that for BDNF p F/AuNP. This latter exhibits a more localized distribution (dotted green emission), with a preferential localization at the cell membrane (solid arrow in Figure 5b ). As to NGF p F-PC/AuNP and BDNF p F-PC/AuNP systems, the cellular internalization is comparable for both peptides, with green spots co-localizing with the AuNPs, also in the nuclei.
CONCLUSIONS
In summary, we set up a new promising approach to develop a "tunable" multifunctional platform based on a neurotrophinlike potential drug (NGF and BDNF peptides) and a plasmonic/fluorescence image-contrast working principle. A modulation in the peptide immobilization was demonstrated by a comparative study (by UV−vis, AFM, DLS, and ZP analyses) of direct and lipid-mediated peptide−AuNP interaction. Further physicochemical and biological (including in vivo test) studies on these hybrid nanobiointerfaces will be necessary to accurately control the subcellular localization of the drug and to quantify the actual capability of crossing the BBB.
EXPERIMENTAL METHODS
4.1. Materials. Ultrapure Milli-Q water (resistivity > 18 MΩ cm −1 ) was used for all experiments. Glassware was cleaned immediately before use by immersing in aqua regia (HCl:HNO 3 , 3:1 volume ratio), followed by rinsing with copious amount of water. Hydrogen tetrachloroaurate (HAuCl 4 ) and trisodium citrate dihydrate (Na 3 C 6 H 5 O 7 · 2H 2 O, TSC) were purchased from Sigma-Aldrich.
4.1.1. Buffers. The phosphate-buffered saline (PBS) solution (pH = 7.4 at 25°C) was prepared by dissolving PBS tablets (0.01 M phosphate, 2.7 mM KCl, 137 mM NaCl, purchased from Sigma-Aldrich) in ultrapure water. The MOPS buffer solution (added with 0.27 mM KCl and 13.7 mM NaCl) was prepared at a concentration of 1 mM, with pH corrected to 7.4 (25°C).
4.1.2. Peptides. The N-terminal fragments (1−14) of NGF (NGF1-14) and (1−12) of BDNF (BDNF1-12) peptides 39, 40 were purchased from Caslo (Lyngby, Denmark) as lyophilized powders (purity > 95%).
To dye-label the peptide with the fluorescein (Fam) group (λ ex /λ em = 488/520 nm), a lysine (Lys) was added at the Cterminus of the peptides sequences, to obtain SSSHPIFHR-GEFSV-K-Fam (named NGF p F) and HSDPARRGELSV-KFam (named BDNF p F). Stock peptide samples were prepared at a concentration of 10 −3 M in Milli-Q water and stored at −20°C.
4.1.3. Lipids. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and rhodamine-labeled 1,2-dihexadecanoyl-snglycero-3-(Rhod-DHPE) phospholipids in chloroform were purchased from Avanti Polar Lipids (Alabaster, AL).
4.2. Preparation of SUV and Peptide/SUV Systems. A chloroform solution of POPC (5 mg/mL) and Rhod-DHPE (1 wt %) was taken in a round-bottom flask, and, after evaporating the solvent under argon flow, the dried lipid film formed on the wall of the flask was emulsified in PBS (to obtain SUV) or 0.5 mM peptide solution in PBS (to obtain N-Fam/SUV or BFam/SUV) and vortexed. The lipid dispersions were therefore extruded 13 times through a 100 nm polycarbonate membrane, followed by another 13 times through a 30 nm membrane (Avanti Polar Lipids).
To remove unloaded peptide molecules from the peptide/ SUV systems, Amicon Ultra-0.5 ultracentrifuge filters (SigmaAldrich) 41 were used to centrifuge (14 000 rpm for 30 min at 25°C) and the recovered solutions were characterized ( Figure  S1 ). The SUV and peptide/SUVs were stored under Ar and used within 2 weeks, according to an established protocol. 2 surfaces were scanned, and the lengths of particles were measured using a freehand tool in the MFP-3DTM offline section analysis software. The same tool was used to measure the cross sections of particles.
4.4.4. XPS. XPS measurements were performed using a PHI 5000 VersaProbe apparatus equipped with a monochromatic Al Kα source (1486.7 eV). Typically, the pressure in the analysis chamber was 5 × 10 −9 torr. The dual-beam charge neutralization method with electron (∼1 eV) and argon ion (<10 eV) guns was used for charge compensation. Au 4f, C 1s, O 1s, N 1s, and S 2p signals were acquired at a constant pass energy and an analyzer energy step of 23.5 and 0.2 eV, respectively. Fitting was then realized with software provided by PHI, with preliminary Shirley background subtraction. Each spectrum is referenced to a carbon pollution at 285.0 eV of BE. All BE values are given at ±0.2 eV.
4.5. Cellular Experiments. 4.5.1. Cell Cultures. Monolayers of iHBMEC (Innoprot, Elexalde Derio, Spain) were fed with endothelial basal medium, supplemented with 5% fetal bovine serum, 1% endothelial cell growth supplement, 100 U/ mL penicillin, and 100 mg/mL streptomycin. 4.5.2. Cell Viability Assays. To evaluate cell viability in ECs, the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrasodium bromide (MTT) assay was used (Chemicon, Temecula, CA). The cells (10 000 cells/well) were plated in 96-well plates and grown in complete medium, in the absence (control cells) or presence of bare or peptide-functionalized AuNPs at a final concentration of 3 nM for 2 and 24 h. At the end of treatment, the cells were incubated with MTT for 3 h, 100 μL of dimethyl sulfoxide was added, and the absorbance was measured at 590 nm, as previously described. At confluence, cells were split on glass-bottom Petri dishes (WillCo Wells; glass diameter, 22 mm) pretreated with a mixture of 30 ng/mL collagen and 10 ng/mL fibronectin (1 h, room temperature), to allow cell adhesion (2 × 10 4 cells/well). The day after, the cells were treated with the various samples at a final concentration of 3.0 × 10 −9 M of the AuNPs. After 2 h of incubation, the cells were washed with the PBS solution (10 mM PBS, 37°C, pH = 7.4), fixed, and stained with the nuclear dye DAPI (ThermoFisher).
LSM was performed with an Olympus FV1000 confocal laser scanning microscope, equipped with diode UV (405 nm, 50 mW), multiline argon (457, 488, and 515 nm; total, 30 mW), HeNe(G) (543 nm, 1 mW), and HeNe(R) (633 nm, 1 mW) lasers. An oil-immersion objective (60xO PLAPON) and spectral filtering system was used. The detector gain was fixed at a constant value, and images were taken, in a sequential mode, for all of the samples at random locations throughout the area of the well.
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